Overexpression of miR-29a and miR-29b is involved in imatinib resistance via abrogated NF1 expression and increased ERK1/2 activation in chronic myeloid leukemia cells. - Tsubaki M; Obana T; Matsuo T; Komori R; Takeda T; Koumoto Y; Usami H; Nagai N; Nishida S (Medical oncology (Northwood, London, England), 2025)